NAD+observational2022

NADH/NAD+ binding and linked tetrameric assembly of the oncogenic transcription factors CtBP1 and CtBP2.

FEBS letters

confidence

Key findings

Biophysical study of NAD(H) binding and tetrameric assembly of CtBP1/2; no clinical or biological endpoints reported.

View source on PubMed (PMID 34997967) ↗

Sample size
N/A
Population
In vitro (CtBP1 and CtBP2 proteins)
Dosing
NAD+ or NADH binding studies
Duration
N/A
Route
in vitro
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

The activation of oncogenic C-terminal binding Protein (CtBP) transcriptional activity is coupled with NAD(H) binding and homo-oligomeric assembly, although the level of CtBP assembly and nucleotide binding affinity continues to be debated. Here, we apply biophysical techniques to address these fundamental issues for CtBP1 and CtBP2. Our ultracentrifugation results unambiguously demonstrate that CtBP assembles into tetramers in the presence of saturating NAD+ or NADH with tetramer to dimer dissociation constants about 100 nm. Isothermal titration calorimetry measurements of NAD(H) binding to CtBP show dissociation constants between 30 and 500 nm, depending on the nucleotide and paralog. Given cellular levels of NAD+ , CtBP is likely to be fully saturated with NAD under physiological concentrations suggesting that CtBP is unable to act as a sensor for NADH levels.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.